Early Inhaled Nitric Oxide Therapy for Term and Near-Term Newborn Infants with Hypoxic Respiratory Failure: Neurodevelopmental Follow-Up

Journal of Pediatrics

Volumn 150, Issue 3, 2007, Pages

  Konduri, G Ganesh ^a   Vohr, Betty ^a   Robertson, Charlene ^a   Sokol, Gregory M ^a   Solimano, Alfonso ^a   Singer, Joel ^a   Ehrenkranz, Richard A ^a   Singhal, Nalini ^a   Wright, Linda L ^a   Van Meurs, Krisa ^a   Stork, Eileen ^a   Kirpalani, Haresh ^a   Peliowski, Abraham ^a   Johnson, Yvette ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; NERVE CELL DIFFERENTIATION; OXYGENATION; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RESPIRATORY FAILURE; SURVIVAL;

EID: 33847310762     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.11.065     Document Type: Article

References (19)

1. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336 (1997) 597-604
2. Roberts J.D., Fineman J.R., Morin F.C., Shaul P.W., Rimar S., Schreiber M.D., et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336 (1997) 605-610
3. Clark R.H., Kueser T.J., Walker M.W., Southgate W.M., Huckaby J.L., Perez J.A., et al., Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 342 (2000) 469-474
4. Davidson D., Barefield E.S., Kattwinkel J., Dudell G., Damask M., Straube R., et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double masked, placebo controlled, dose-response, multicenter study. Pediatrics 101 (1998) 325-334
5. American Academy of Pediatrics Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics 106 (2000) 344-345
6. Konduri G.G., Solimano A., Sokol G.M., Singer J., Ehrenkranz R.A., Singhal N., et al., Neonatal Inhaled Nitric Oxide Study Group. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 113 (2004) 559-564
7. Bayley N. Bayley Scales of Infant Development II (1993), Psychological Corp, San Antonio, TX
8. Amiel-Tison C. Neuromotor status. In: Taeush H.W., and Yogman M.W. (Eds). Follow-up management of the high risk infant (1987), Little, Brown, Boston 115-126
9. Northern J., and Downs M. Hearing in children (1978), Williams & Wilkins, Baltimore
10. Barker L.E., Luman E.T., McCauley M.M., and Chu S.Y. Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage. Am J Epidemiol 156 (2002) 1056-1061
11. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS). J Pediatr 136 (2000) 611-617
12. Cheung P.Y., Tyebkhan J.M., Peliowski A., Ainsworth W., and Robertson C.M. Prolonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. J Pediatr 135 (1999) 233-239
13. Cheung P.Y., Haluschak M.M., Finer N.N., and Robertson C.M. Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Early Hum Dev 44 (1996) 225-233
14. Marron M.J., Crisafi M.A., Driscoll Jr. J.M., Wung J.T., Driscoll Y.T., Fay T.H., et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 90 (1992) 392-396
15. Hendricks-Munoz K.D., and Walton J.P. Hearing loss in infants with persistent fetal circulation. Pediatrics 81 (1988) 650-656
16. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350 (2004) 1304-1313
17. Vohr B.R., Wright L.L., Poole W.K., and McDonald S.A. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics 116 (2005) 635-643
18. Rosenberg A.A., Kennaugh J.M., Moreland S.G., Fashaw L.M., Hale K.A., Torielli F.M., et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 131 Pt 1 (1997) 70-75
19. Lipkin P.H., Davidson D., Spivak L., Straube R., Rhines J., and Chang C.T. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 140 (2002) 306-310